Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Rahul Shah of Motilal Oswal recommends buying Aurobindo Pharma, Federal Bank and Hindalco Industries.
According to Ashwani Gujral of ashwanigujral.com, one can buy Aurobindo Pharma, Reliance Capital and CESC and sell PC Jeweller.
Mitessh Thakkar of mitesshthakkar.com is of the view that one can buy Aurobindo Pharma, Bajaj Finserv and Bharat Electronics and sell Motherson Sumi Systems.
Ashwani Gujral of ashwanigujral.com recommends buying TVS Motor, Aurobindo Pharma and Wockhardt.
Mitessh Thakkar of miteshthacker.com suggests buying Dr Reddy's Laboratories and Aurobindo Pharma.
According to Rajat Bose of rajatkbose.com , one can buy CESC, Aurobindo Pharma and Hindustan Petroleum Corporation.
Sudarshan Sukhani of s2analytics.com recommends buying BPCL, Hindalco Industries and Hexaware Technologies and advises shorting Aurobindo Pharma and Godfrey Phillips.
Sudip Bandopadhyay, Market Expert recommends buuying Aurobindo Pharma, Natco Pharma and Glenmark Pharma and expects more than 20 percent upside in one year.
Sudip Bandhopadhyay, Market Expert is of the view that one can buy Aurobindo Pharma and likes Glenmark Pharma as well as Natco Pharma..
Shahina Mukadam, Independent Market Expert suggests buying Aurobindo Pharma, Lupin and Fortis Healthcare.
According to Prakash Gaba of prakashgaba.com, 9700 is a crucial support to work with and 9900 is the resistance to deal with. Volatility is not ruled out as this is a truncated week. The crucial support for Nifty is at 9700-9640 and the resistance is at 9900. On the other hand, Bank Nifty has support at 23750 and resistance at 24300.
Ashwani Gujral of ashwanigujral.com recommends selling Tata Motors DVR, LIC Housing Finance and CESC and advises also selling Aurobindo Pharma on rally.
Sudarshan Sukhani of s2analytics.com recommends buying Zee Entertainment, Tata Consultancy Services and NTPC and advises selling Jain Irrigation Systems and Castrol India.
Aurobindo, Eicher Motors and Bank of India, among others, are on the radar of investors on Thursday.
In an interview to CNBC-TV18, Surajit Pal, Pharma Analyst at Prabhudas Lilladher shared his views and readings on the latest happenings in pharmaceutical space especially on Sun Pharmaceutical Industries and Aurobindo Pharma.
Ashwani Gujral of ashwanigujral.com is of the view that one may buy Raymond and sell Aurobindo Pharma and SRF.
Sun Pharma is n focus after Taro, its US arm, reports a 30 percent decline in net sales. In an interview to CNBC-TV18, Amey Chalke, Research Analyst at HDFC Securities shared his readings and outlook on the same as well as on some other pharma stocks.
In an interview to CNBC-TV18, SP Tulsian of sptulsian.com in which he shared his readings and outlook on market and specific stocks.
In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian of sptulsian.com shared his views and outlook on the fundamentals of the market and specific stocks.
Sudarshan Sukhani of s2analytics.com suggests buying GAIL India, Larsen and Toubro and Ujjivan Financial Services and advises selling Aurobindo Pharma and NTPC.
In an interview to CNBC-TV18's Surabhi Upadhyay and Prashant Nair, SP Tulsian of sptulsian shared his views and outlook on the fundamentals of the market and specific stocks.
Rajat Bose of rajatkbose.com is of the view that one may buy Reliance Industries and Aurobindo Pharma and can sell ICICI Bank futures.
Ashwani Gujral of ashwanigujral.com recommends buying Aurobindo Pharma, Hindustan Unilever, Tata Steel and IndusInd Bank.
According to Prakash Gaba of prakashgaba.com, the trend is still up as long as 10000 holds. The crucial support for Nifty is at 10000 and the resistance is at 10149-10260-10536. On the other hand, bankers expect RBI to change its monetary stance and may even go for an aggressive rate cut.
Ashwani Gujral of ashwanigujral.com is of the view that one may buy Aurobindo Pharma, SREI Infrastructure and LIC Housing Finance.